Om Kurmi | Community Medicine | Best Researcher Award

Dr. Om Kurmi | Community Medicine | Best Researcher Award

Associate Professor, Coventry University, United Kingdom

🌍 Dr. Om Prakash Kurmi is an esteemed epidemiologist and public health researcher with a wealth of experience at globally recognized institutions. His work focuses on understanding the impacts of environmental and occupational factors on health, addressing pressing global health issues. Currently, he is a professor at McMaster University in the Department of Medicine, contributing valuable research to global health initiatives.

Publication Profile

Scopus

Education

πŸŽ“ Dr. Kurmi earned his PhD in Public Health from the University of Aberdeen, UK, in 2010. His doctoral research laid a strong foundation in epidemiology and public health, emphasizing the influences of environmental and occupational hazards on population health.

Experience

πŸ›οΈ Dr. Kurmi’s academic journey includes notable roles at prestigious institutions. He is currently an Assistant Professor in Medicine at McMaster University and has previously held positions at the University of Oxford and the University of Birmingham, where he was a Research Fellow in the Institute of Occupational and Environmental Medicine.

Research Focus

πŸ”¬ Dr. Kurmi’s research targets the intersections of environmental and occupational health with epidemiology. His studies often address the impacts of air pollution and workplace hazards on mortality and morbidity, aiming to inform public health policies worldwide. He has made significant contributions to global health assessments and evidence-building around risk factors.

Awards and Honours

πŸ… Dr. Kurmi has received recognition for his contributions to public health research, including acknowledgments from major academic bodies and institutions for his dedication to environmental health epidemiology and impactful research.

Publication Highlights

“Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the COVID-19 pandemic”, The Lancet, 2024, cited by numerous subsequent studies addressing pandemic impacts.

“Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021”, The Lancet, 2024, frequently referenced for its comprehensive analysis of health risk factors globally.

“Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021”, The Lancet, 2024, a pivotal resource in mortality and life expectancy studies worldwide.

 

Shahab Reaeian | Prevention | Best Researcher Award

Assoc Prof Dr. Shahab Reaeian | Prevention | Best Researcher Award

Academic member, Kermanshah University of Medical Sciences, Iran

Dr. Shahab Rezaeian is an esteemed epidemiologist from Iran, specializing in public health and epidemiology. With a PhD from Shiraz University of Medical Sciences, he has dedicated his career to understanding the dynamics of diseases and their impact on communities. He is currently a faculty member at Kermanshah University of Medical Sciences, contributing to the field through both research and education. πŸ©ΊπŸ“š

Publication Profile

Google scholar

Education

Dr. Rezaeian earned his B.S. in Public Health from Iran University of Medical Sciences in 2007, followed by an MSc in Epidemiology from Hamadan University of Medical Sciences in 2012. He completed his PhD in Epidemiology at Shiraz University of Medical Sciences in 2016, focusing his research on the survival trends and blood demand of beta-thalassemia patients. πŸŽ“

Experience

Dr. Rezaeian has extensive experience in epidemiological research, particularly in assessing the risk factors for various health conditions, including congenital hypothyroidism and HIV. His professional journey reflects a commitment to advancing public health through rigorous data analysis and interpretation. πŸ’Ό

Research Focus

His primary research interests include epidemiological modeling, public health interventions, and the study of congenital conditions. Dr. Rezaeian aims to contribute to effective health policies and practices by analyzing health data and identifying key determinants of health outcomes. πŸ”¬πŸ“ˆ

Awards and Honours

Dr. Rezaeian has received several accolades for his contributions to epidemiology and public health, including recognition for his impactful research publications and involvement in various health initiatives. His work continues to inspire future generations of health professionals. πŸ†

Publication Top Notes

Dr. Rezaeian has authored numerous significant publications in reputable journals, contributing to the scientific community’s understanding of epidemiology and public health. Some notable works include:

Influenza A (H1N1) in Hamedan Province, Western Iran in 2009: A Case-Control Study (2010, J Res Health Sci) – Cited by 30

Quality of Cohort Studies Reporting Post the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement (2011, Epidemiology and Health) – Cited by 50

The Quality of the Reporting of Randomized Controlled Trials after CONSORT Statement in the Prestigious Journals (2013, Shiraz E Medical Journal) – Cited by 40

Difference in the Incidence of Congenital Hypothyroidism Among World Countries (2013, Ann Saudi Med) – Cited by 20

Social Determinants of Health Associated with Self-Reported HIV Testing Among Women (2013, Iran J Public Health) – Cited by 35

Risk Factors of Congenital Hypothyroidism Using Propensity Score: A Matched Case-Control Study (2013, J Res Health Sci) – Cited by 25